| Bayer Crop Sci. |
Bayer CropScience Limited will close its trading window for designated persons from October 1, 2026, until the declaration of its quarterly financial results for the quarter ended September 30, 2026, and two days thereafter, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. |
| Citurgia Biochem |
Citurgia Biochemicals Limited has received approval from the Registrar of Companies, Mumbai, granting a one-month extension to convene its 51st Annual General Meeting (AGM) for the financial year ended March 31, 2026, allowing the company to hold the meeting on or before October 31, 2026. The extension was requested due to circumstances outlined in a letter attached to e-form SRN AC5761930 submitted on September 1, 2026, and follows prior board approval on August 31, 2026, to seek a three-month extension. |
| Nestle India |
Nestlé India Limited clarified on September 18, 2026, that a recent news item appearing on moneycontrol.com regarding legal action by the Food Safety and Standards Authority of India (FSSAI) on baby formula products NAN EXCELLA PRO and LACTOGEN PRO is factually incorrect, stating the products and their labels were approved by an FSSAI expert committee and that the company adheres to all applicable regulations. |
| GE Shipping Co |
The Great Eastern Shipping Company Limited announced it bought back 104,658 equity shares on September 18, 2026, through Kotak Securities Limited, bringing the total number of shares repurchased under the buyback program to 14,20,415, with an average acquisition price of Rs 1426.0789. |
| Guj. Themis Bio. |
Gujarat Themis Biosyn Limited (GTBL) has completed the acquisition of MicroBiopharm Japan Co., Ltd. (MBJ), Japan, through its wholly-owned subsidiary, Themis Biosyn Japan Limited (TBJ), for a total consideration of JPY 21.5 billion, funded through a mix of debt and equity. GTBL invested Rs 475 Crores towards capital contribution and Rs 745 Crores by way of loan in TBJ, and has entered into a loan agreement with TBJ for an amount up to Rs 800 Crores. The acquisition, which accelerates GTBL’s transition towards a fermentation-based, globally integrated contract development and manufacturing organization (CDMO), was made from funds managed or advised by T Capital Partners Co., Ltd. |